US10174284B2ActiveUtilityPatentIndex 45
Medium, for culturing corneal endothelial cells, containing conditioned medium from mesenchymal stem cells
Est. expirySep 7, 2032(~6.2 yrs left)· nominal 20-yr term from priority
Inventors:HAGIYA MICHIOIMAGAWA KIWAMUHOSODA YUUKIKOIZUMI NORIKOOKUMURA NAOKINAKAHARA MAKIKOKINOSHITA SHIGERU
C12N 2502/1358C12N 5/0621C12N 5/0018A61K 35/44A61P 27/02C12N 2500/84A61K 35/30
45
PatentIndex Score
0
Cited by
30
References
14
Claims
Abstract
[Problem] To provide, in order to manufacture cells to transplant into patients with corneal endothelial failure, a medium used to culture corneal endothelial cells obtained from human corneal tissue and grow said cells while maintaining the morphology thereof as corneal endothelial cells. [Solution] A medium containing a conditioned medium from mesenchymal stem cells; and a method in which said medium is used to culture corneal endothelial cells.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method for culturing human corneal endothelial cells, which comprises
a step for preparing a conditioned medium by culturing a mesenchymal stem cell in a medium containing chondroitin sulfate,
a step for separating the human corneal endothelial cells from a corneal tissue, and
a step for propagating the separated human corneal endothelial cells by a culture using a medium for corneal endothelial cell culture consisting of the conditioned medium of mesenchymal stem cells or containing the conditioned medium wherein the mesenchymal stem cell is a human mesenchymal stem cell and wherein the concentration of chondroitin sulfate is 0.04 to 0.12 % (w/v).
2. The method according to claim 1 , wherein the medium for corneal endothelial cell culture contains the conditioned medium in a proportion of 0.5 to 50 % (v/v).
3. The method according to claim 1 , wherein the medium for corneal endothelial cell culture contains the conditioned medium in a proportion of 1to 10 % (v/v).
4. The method according to claim 1 , wherein the concentration of chondroitin sulfate is 0.08 % (w/v).
5. The method according to claim 1 , wherein the mesenchymal stem cell is a mesenchymal stem cell derived from human bone marrow.
6. A method for culturing human corneal endothelial cells, which comprises
a step for preparing a conditioned medium by culturing a mesenchymal stem cell in a medium containing chondroitin sulfate,
a step for preparing a concentrated solution by filtration concentration of the conditioned medium,
a step for separating the human corneal endothelial cells from a corneal tissue, and
a step for propagating the separated human corneal endothelial cells by a culture using a medium for corneal endothelial cell culture containing the concentrated solution wherein the mesenchymal stem cell is a human mesenchymal stem cell and wherein the concentration of chondroitin sulfate is 0.04 to 0.12 % (w/v).
7. The method according to claim 6 , wherein the concentration rate in the filtration concentration is 2 to 30 times.
8. The method according to claim 6 , wherein the concentration rate in the filtration concentration is 15 to 20 times.
9. The method according to claim 6 , wherein the medium for corneal endothelial cell culture contains the concentrated solution at a proportion of 0.5 to 50 % (v/v).
10. The method according to claim 6 , wherein the medium for corneal endothelial cell culture contains the concentrated solution at a proportion of 1 to 10 % (v/v).
11. The method according to claim 6 , wherein the concentration of chondroitin sulfate is 0.08 % (w/v).
12. The method according to claim 6 , wherein the mesenchymal stem cell is a mesenchymal stem cell derived from human bone marrow.
13. The method according to claim 1 , wherein the medium for corneal endothelial cell culture is not added with nerve growth factor.
14. The method according to claim 6 , wherein the medium for corneal endothelial cell culture is not added with nerve growth factor.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.